ClinicalTrials.Veeva

Menu

Risk Factors for Linezolid Resistance in Staphylococcus Aureus

University of Pittsburgh logo

University of Pittsburgh

Status

Completed

Conditions

Linezolid Resistance
Staphylococcus Aureus

Study type

Observational

Funder types

Other

Identifiers

NCT00519025
investigator funding (Other Identifier)
PRO07080006

Details and patient eligibility

About

This is a retrospective chart review study. The proposed study aims to document the risk factors for quinolone resistance in bloodstream isolates of Klebsiella species. Additionally, the adequacy of empiric antibiotic therapy for Klebsiella bloodstream infections will be assessed.

Full description

This is a retrospective chart review study. The proposed study aims to document the risk factors for quinolone resistance in bloodstream isolates of Klebsiella species. Additionally, the adequacy of empiric antibiotic therapy for Klebsiella bloodstream infections will be assessed. This research is important because identification of risk factors may allow earlier initiation of appropriate therapy in patients infected with these bacteria. Additionally, we will identify whether horizontal spread is responsible for this increasing trend.

Enrollment

360 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients with linezolid resistance to staphylococcus aureus

Exclusion criteria

  • those that don't meet entry criteria

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems